Abstract
Lung transplantation is one of the most challenging procedures and requires a specialized cardiothoracic anesthesiologist. Adequate preoperative assessment is necessary to objectify underlying diseases and the impact of pulmonary diseases on hemodynamics. High vigilance and skills in managing acute hemodynamic and ventilation changes are essential. The anesthesiologist must be knowledgeable in single lung ventilation, extracorporeal circulation devices and echocardiography examination. This chapter provides guidance on how to take care of patients undergoing such a procedure.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Levy B, Fritz C, Tahon E, Jacquot A, Auchet T, Kimmoun A. Vasoplegia treatments: the past, the present, and the future. Crit Care. 2018;22:52.
Sarkar J, Golden PJ, Kajura LN, Murata LA, Uyehara CF. Vasopressin decreases pulmonary-to-systemic vascular resistance ratio in a porcine model of severe hemorrhagic shock. Shock. 2015;43:475–82.
Barnes L, Reed RM, Parekh KR, Bhama JK, Pena T, Rajagopal S, Schmidt GA, Klesney-Talt JA, Eberlein M. Mechanical ventilation for the lung transplant recipient. Curr Pulmonol Rep. 2015;4:88–96.
Verbeek GL, Myles PS, Westall GP, Lin E, Hastings SL, Marasco SF, Jaffar J, Meehan AC. Intra-operative protective mechanical ventilation in lung transplantation: a randomised, controlled trial. Anaesthesia 2017;72:993–1004.
Geube MA, Perez-Protto SE, McGrath TL, Yang D, Sessler DI, Budev MM, Kurz A, McCurry KR, Duncan AE, et al. Increased intraoperative fluid administration is associated with severe primary graft dysfunction after lung transplantation. Anesth Analg. 2016;122(4):1081–8.
Snell GI, Yussen RD, Weill D, Strueber M, Garrity E, Reed A, Pelaez A, Wjelan TP, Perch M, Bag R, Budev M, Corris PA, Crespo MM, Witt C, Cantu E, Christie JD. Report of the ISHLT Working Group on Primary Lung Graft dysfunction, part 1: definition and grading-A 2016 consensus group statement of the International Society of Heart and Lung Transplantation. J Heart Lung Transpl. 2017;36:1097–103.
Machuzak M, Santacruz JF, Gildea T, Murthy SC. Airway complications after lung transplantation. Thorac Surg Clin. 2015;25:55–75.
Bottero S, Meucci D, Trozzi M, Carotti A. Dehiscence of bronchial anastomosis after lung transplantation: a successful unconventional treatment. Ann Thorac Surg. 2018;106:e81–3.
Levine DJ, Glanville AR, Aboyoun C, Belperio J, Benden C, Berry GJ, Hachem R, Hayes D Jr, Neil D, Reinsmoen NL, Snyder LD, Sweet S, Tyan D, Verleden G, Westall G, Yusen RD, Zamora M, Zeevi A. Antibody-mediated rejection of the lung: a consensus report of the International Society for Heart and Lung Transplantation. J Heart Lung Transpl. 2016;35:397–406.
Magouliotis DE, Tasiopoulou VS, Svokos AA, Svokos KA, Zacharoulis D. Extracorporeal membrane oxygenation versus cardiopulmonary bypass during lung transplantation: a meta-analysis. Gen Thorac Cardiovasc Surg. 2018;66:38–47.
Mohite PN, Sabashnikov A, Patil NP, Garcia-Saez D, Zych B, Zeriouh M, Romano R, Soresi S, Reed A, Carby M, De Robertis F, Bahrami T, Amrani M, Marczin N, Simon AR, Popov AF. The role of cardiopulmonary bypass in lung transplantation. Clin Transpl. 2016;30:202–9.
Dzierba AL, Abrams D, Brodie D. Medicating patients during extracorporeal membrane oxygenation; the evidence is building. Crit Care. 2017;21:66.
Lemaitre F, Hasni N, Leprince P, Corvol E, Belhabib G, Fillâtre P, Luyt CE, Leven C, Farinotti R, Fernandez C, Combes A. Propofol, midazolam, vancomycin and cyclosporine therapeutic drug monitoring in extracorporeal membrane oxygenation circuits primed with whole human blood. Crit Care. 2015;19:40.
Parasuraman S, Walker S, Loudon BL, Gollop ND, Wilson AM, Lowery C, Frenneaux MP. Assessment of pulmonary artery pressure by echocardiography-A comprehensive review. Int J Cardiol Heart Vasc. 2016;12:45–51.
Rajagopal K, Griffith BP. Oxford textbook of critical care. 2nd ed. UK: Oxford University Press; 2016.
Porteous MK, Ky B, Kirkpatrick JN, Shinohara R, Diamond JM, Shah RJ, Lee JC, Christie JD, Kawut SM. Diastolic dysfunction increases the risk of primary graft dysfunction after lung transplant. Am J Respir Crit Care Med. 2016;193:1392–400.
Further Reading and Related Links/Journals/Book
Holmes CL, Landry DW, Granton JT. science review: vasopressin and the cardiovascular system part 2—clinical physiology. Crit Care. 2004;1:15–23.
Noguera I, Medina P, Segarra G, Martínez MC, Aldasoro M, Vila JM, Lluch S. Potentiation by vasopressin of adrenergic vasoconstriction in the rat isolated mesenteric artery. Br J Pharmacol. 1997;122:431–8.
Maybauer MO, Maybauer DM, Enkhbaatar P, Laporte R, Wiśniewska H, Traber LD, Lin CD, Fan J, Hawkins HK, Cox RA, Wiśniewski K, Schteingart CD, Landry DW, Rivière PJ, Traber DL. The selective vasopressin type 1a receptor agonist selepressin (FE202158) blocks vascular leak in ovine severe sepsis. Crit Care Med. 2014;42:e525–33.
Evora PR, Pearson PJ, Schaff HV. Arginine vasopressin induces endothelium-dependent vasodilatation of the pulmonary artery. V1-receptor-mediated production of nitric oxide. Chest. 1993;103:1241–1245.
Mascia L, Pasero D, Slutsky AS, Arguis MJ, Berardino M, Grasso S, Munari M, Boifava S, Cornara G, Della Corte F, Vivaldi N, Malacarne P, Del Gaudio P, Livigni S, Zavala E, Filippini C, Martin EL, Donadio PP, Mastromauro I, Ranieri VM. Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation: a randomize controlled trial. JAMA. 2010;304:2620–7.
Christie JD, Van Raemdonck D, de Perrot M, Barr M, Keshavjee S, Arcasoy S, Orens J. Report of the ISHL Working Group on Primary Lung Graft dysfunction Part II: definition. A consensus Statement of the International Society of Heart and Lung Transplantation. J Heart Lung Transpl. 2005;24:1451–1459.
Lee JC, Christie JD. Primary graft dysfunction. Clin Chest Med. 2011;32:279–93.
Shah RJ, Bellamy SL, Localio AR, Wickersham N, Diamond JM, Weinacker A, Lama VN, Bhorade S, Belperio JA, Crespo M, Demissie E, Kawut SM, Wille KM, Lederer DJ, Lee JC, Palmer SM, Orens J, Reynolds J, Shah A, Wilkes DS, Ware LB, Christie JD. A panel of lung injury biomarkers enhances the definition of primary graft dysfunction (PGD) after lung transplantation. J Heart Lung Transpl. 2012;31:942–9.
Suzuki Y, Cantu E, Christie JD. Primary graft dysfunction. Semin Respir Crit Care Me. 2013;34:305–19.
Ray M, Dharmarajan S, Freudenberg J, Zhang W, Patterson GA. Expression profiling of human donor lungs to understand primary graft dysfunction after lung transplantation. Am J Transpl. 2007;7:2396–405.
Fischer S, Cassivi SD, Xavier AM, Cardella JA, Cutz E, Edwards V, Liu M, Keshavjee S. Cell death in human lung transplantation: apoptosis induction in human lungs during ischemia and after transplantation. Ann Surg. 2000;231:424–31.
Diamond JM, Lee JC, Kawut SM, Shah RJ, Localio AR, Bellamy SL, Lederer DJ, Cantu E, Kohl BA, Lama VN, Bhorade SM, Crespo M, Demissie E, Sonett J, Wille K, Orens J, Shah AS, Weinacker A, Arcasoy S, Shah PD, Wilkes DS, Ware LB, Palmer SM, Christie JD, Lung Transplant Outcomes Group. Clinical risk factors for primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med 2013;187:527–534.
Schulman LL, Anandarangam T, Leibowitz DW, Ditullio MR, McGregor CC, Galantowicz ME, Homma S. Four-year prospective study of pulmonary venous thrombosis after lung transplantation. J Am Soc Echocardiogr. 2001;14:806–12.
Christie JD, Carby M, Bag R, Corris P, Hertz M, Weill D. Report of the ISHL Working Group on Primary Lung Graft dysfunction Part II: definition. A consensus Statement of the International Society of Heart and Lung Transplantation. J Heart Lung Transplant 2005;24:1451–1459.
De Gracia J, Culebras M, Alvarez A, Catalán E, De la Rosa D, Maestre J, Canela M, Román A. Bronchoscopic balloon dilatation in the management of bronchial stenosis following lung transplantation. Respir Med. 2007;101:27–33.
Lobo LJ, Aris RM, Schmitz J, Neuringer IP. Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantation. J Heart Lung Transpl. 2013;32:70–7.
Hachem RR, Yusen RD, Meyers BF, Aloush AA, Mohanakumar T, Patterson GA, Trulock EP. Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation. J Heart Lung Transpl. 2010;29:973–80.
Shekar K, Fraser JF, Smith MT, Roberts JA. Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenation. J Crit Care. 2012;27(741):e9–18.
Wagner D, Pasko D, Phillips K, Waldvogel J, Annich G. In vitro clearance of dexmedetomidine in extracorporeal membrane oxygenation. Perfusion. 2013;28:40–6.
Liu N, Chazot T, Trillat B, Michel-Cherqui M, Marandon JY, Law-Koune JD, Rives B, Fischler M; Foch Lung Transplant Group. Closed-loop control of consciousness during lung transplantation: an observational study. J Cardiothorac Vasc Anesth 2008;22:611–615.
González-Fernández C, González-Castro A, Rodríguez-Borregán JC, López-Sánchez M, Suberviola B, Francisco Nistal J, Martín-Durán R. Pulmonary venous obstruction after lung transplantation. Diagnostic advantages of transesophageal echocardiography. Clin Transpl. 2009;23:975–980.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
de Waal, E.E.C., Kachulis, B., Pospishil, L., Marczin, N. (2020). Anesthesia in Lung Transplantation. In: Nistor, C.E., Tsui, S., Kırali, K., Ciuche, A., Aresu, G., Kocher, G.J. (eds) Thoracic Surgery. Springer, Cham. https://doi.org/10.1007/978-3-030-40679-0_80
Download citation
DOI: https://doi.org/10.1007/978-3-030-40679-0_80
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-40678-3
Online ISBN: 978-3-030-40679-0
eBook Packages: MedicineMedicine (R0)